We have located links that may give you full text access.
A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor.
Journal of Rheumatology 2024 June 18
Dermatomyositis (DM) with myositis-specific autoantibodies (MSAs) such as anti-Mi-2 antibody confers a negative risk for malignancy.1 A diagnosis of DM carries a 24% risk of developing a malignancy.2 .
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app